Importantly, DARPP-32 and t-DARPP-mediated signaling in NSCLC have been shown to promote cell survival and migration, and increasing t-DARPP was associated with increased tumor size and poorer prognosis (1). This evidence concerns the gene PPP1R1B and neoplasm.